ArticleESMO open2025

Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor board.

E Krieghoff-Henning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.